Skip to main content
Top
Published in: Current Cardiology Reports 10/2015

01-10-2015 | Peripheral Vascular Disease (MR Jaff, Section Editor)

Stroke: Advances in Medical Therapy and Acute Stroke Intervention

Authors: Kevin M. Barrett, Brajesh K. Lal, James F. Meschia

Published in: Current Cardiology Reports | Issue 10/2015

Login to get access

Abstract

Evidence-based therapeutic options for stroke continue to emerge based on results from well-designed clinical studies. Ischemic stroke far exceeds hemorrhagic stroke in terms of prevalence and incidence, both in the USA and worldwide. The public health effect of reducing death and disability related to ischemic stroke justifies the resources that have been invested in identifying safe and effective treatments. The emergence of novel oral anticoagulants for ischemic stroke prevention in atrial fibrillation has introduced complexity to clinical decision making for patients with this common cardiac arrhythmia. Some accepted ischemic stroke preventative strategies, such as carotid revascularization for asymptomatic carotid stenosis, require reassessment, given advances in risk factor management, antithrombotic therapy, and surgical techniques. Intra-arterial therapy, particularly with stent retrievers after intravenous tissue plasminogen activator, has recently been demonstrated to improve functional outcomes and will require investment in system-based care models to ensure that effective treatments are received by patients in a timely fashion. The purpose of this review is to describe recent advances in medical and surgical approaches to ischemic stroke prevention and acute treatment. Results from recently published clinical trials will be highlighted along with ongoing clinical trials addressing key questions in ischemic stroke management and prevention where equipoise remains.
Literature
1.
go back to reference Björck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44(11):3103–8.CrossRefPubMed Björck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44(11):3103–8.CrossRefPubMed
2.
go back to reference Camm AJ, Lip GY, De Caterina R, ESC Committee for Practice Guidelines-CPG; Document Reviewers, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Europace. 2012;14(10):1385–413.CrossRefPubMed Camm AJ, Lip GY, De Caterina R, ESC Committee for Practice Guidelines-CPG; Document Reviewers, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Europace. 2012;14(10):1385–413.CrossRefPubMed
3.
go back to reference Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–70.CrossRefPubMed Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–70.CrossRefPubMed
4.
go back to reference Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137(2):263–72.CrossRefPubMed Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137(2):263–72.CrossRefPubMed
5.
go back to reference January CT, Wann LS, Alpert JS, American College of Cardiology/American Heart Association Task Force on Practice Guidelines, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–e76.CrossRefPubMed January CT, Wann LS, Alpert JS, American College of Cardiology/American Heart Association Task Force on Practice Guidelines, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–e76.CrossRefPubMed
6.
go back to reference Lip GY, Andreotti F, Fauchier L, European Heart Rhythm Association, et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive summary of a position document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost. 2011;106(6):997–1011.CrossRefPubMed Lip GY, Andreotti F, Fauchier L, European Heart Rhythm Association, et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive summary of a position document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost. 2011;106(6):997–1011.CrossRefPubMed
7.
go back to reference Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3):713–9.CrossRefPubMed Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3):713–9.CrossRefPubMed
8.
go back to reference Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1 year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093–100.CrossRefPubMed Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1 year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093–100.CrossRefPubMed
9.
go back to reference Roldán V, Marín F, Manzano-Fernández S, et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2013;62(23):2199–204.CrossRefPubMed Roldán V, Marín F, Manzano-Fernández S, et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2013;62(23):2199–204.CrossRefPubMed
10.
go back to reference Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet. 2014;383(9921):955–62.CrossRefPubMed Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet. 2014;383(9921):955–62.CrossRefPubMed
11.••
go back to reference Lip GY, Lane DA. Stroke prevention in atrial fibrillation: a systematic review. JAMA. 2015;313(19):1950–62. Comprehensive evidence-based review of current concepts and recent developments in stroke prevention in AF. The article is clinically focused with practical suggestions for management of oral anticoagulation for stroke prevention.CrossRefPubMed Lip GY, Lane DA. Stroke prevention in atrial fibrillation: a systematic review. JAMA. 2015;313(19):1950–62. Comprehensive evidence-based review of current concepts and recent developments in stroke prevention in AF. The article is clinically focused with practical suggestions for management of oral anticoagulation for stroke prevention.CrossRefPubMed
12.
go back to reference Pfeilschifter W, Abruscato M, Hövelmann S, et al. Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases. Case Rep Neurol. 2013;5:56–61.PubMedCentralCrossRefPubMed Pfeilschifter W, Abruscato M, Hövelmann S, et al. Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases. Case Rep Neurol. 2013;5:56–61.PubMedCentralCrossRefPubMed
13.
go back to reference Rybinnik I, Mullen MT, Messe S, et al. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists. J Stroke Cerebrovasc Dis. 2013;22(8):1312–6.CrossRefPubMed Rybinnik I, Mullen MT, Messe S, et al. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists. J Stroke Cerebrovasc Dis. 2013;22(8):1312–6.CrossRefPubMed
14.
go back to reference Paciaroni M, Agnelli G, Micheli S, et al. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke. 2007;38:423–30.CrossRefPubMed Paciaroni M, Agnelli G, Micheli S, et al. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke. 2007;38:423–30.CrossRefPubMed
15.
go back to reference White H, Boden-Albala B, Wang C, Elkind MSV, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111(10):1327–31.CrossRefPubMed White H, Boden-Albala B, Wang C, Elkind MSV, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111(10):1327–31.CrossRefPubMed
16.
go back to reference Petty GW, Brown Jr RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30(12):2513–6.CrossRefPubMed Petty GW, Brown Jr RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30(12):2513–6.CrossRefPubMed
17.
go back to reference Hobson 2nd RW, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328(4):221–7.CrossRefPubMed Hobson 2nd RW, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328(4):221–7.CrossRefPubMed
18.
go back to reference Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273(18):1421–8.CrossRef Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273(18):1421–8.CrossRef
19.
go back to reference Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363(9420):1491–502.CrossRefPubMed Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363(9420):1491–502.CrossRefPubMed
20.
go back to reference Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40:e573–83.CrossRefPubMed Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40:e573–83.CrossRefPubMed
21.
go back to reference Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke. 2010;41:e11–7.CrossRefPubMed Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke. 2010;41:e11–7.CrossRefPubMed
22.
go back to reference Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10 years stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376:1074–84.PubMedCentralCrossRefPubMed Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10 years stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376:1074–84.PubMedCentralCrossRefPubMed
23.
go back to reference Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358(15):1572–9.CrossRefPubMed Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358(15):1572–9.CrossRefPubMed
24.
go back to reference Brott TG, Hobson 2nd RW, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.PubMedCentralCrossRefPubMed Brott TG, Hobson 2nd RW, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.PubMedCentralCrossRefPubMed
25.
go back to reference Rubin MN, Barrett KM, Brott TG, Meschia JF. Asymptomatic carotid stenosis: what we can learn from the next generation of randomized clinical trials. JRSM Cardiovasc Dis. 2014;3:2048004014529419.PubMedCentralPubMed Rubin MN, Barrett KM, Brott TG, Meschia JF. Asymptomatic carotid stenosis: what we can learn from the next generation of randomized clinical trials. JRSM Cardiovasc Dis. 2014;3:2048004014529419.PubMedCentralPubMed
26.
go back to reference Lal BK, Meschia JF, Brott TG. CREST-2: guiding treatments for asymptomatic carotid disease. Endovasc Today. 2013;73–6. Lal BK, Meschia JF, Brott TG. CREST-2: guiding treatments for asymptomatic carotid disease. Endovasc Today. 2013;73–6.
27.
go back to reference Reiff T, Stingele R, Eckstein HH, Fraedrich G, Jansen O, Mudra H, et al. Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2—a three-arm randomised-controlled clinical trial. Int J Stroke. 2009;4(4):294–9.CrossRefPubMed Reiff T, Stingele R, Eckstein HH, Fraedrich G, Jansen O, Mudra H, et al. Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2—a three-arm randomised-controlled clinical trial. Int J Stroke. 2009;4(4):294–9.CrossRefPubMed
28.••
go back to reference Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Investigators MC, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. The first clinical trial to demonstrate the benefit of intra-arterial stroke therapy using contemporary device technology (stentrievers). The results have changed the current therapeutic approach to ischemic stroke patients with large vessel occlusion in the anterior circulation.CrossRefPubMed Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Investigators MC, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. The first clinical trial to demonstrate the benefit of intra-arterial stroke therapy using contemporary device technology (stentrievers). The results have changed the current therapeutic approach to ischemic stroke patients with large vessel occlusion in the anterior circulation.CrossRefPubMed
29.
go back to reference Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, for the EXTEND-IA Investigators, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.CrossRefPubMed Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, for the EXTEND-IA Investigators, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.CrossRefPubMed
30.
go back to reference Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, for the ESCAPE Trial Investigators, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30.CrossRefPubMed Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, for the ESCAPE Trial Investigators, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30.CrossRefPubMed
Metadata
Title
Stroke: Advances in Medical Therapy and Acute Stroke Intervention
Authors
Kevin M. Barrett
Brajesh K. Lal
James F. Meschia
Publication date
01-10-2015
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 10/2015
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-015-0637-1

Other articles of this Issue 10/2015

Current Cardiology Reports 10/2015 Go to the issue

Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)

Management of Depression After Myocardial Infarction

Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)

Emotional Triggering of Cardiac Dysfunction: The Present and Future

Stroke (D Wang, Section Editor)

Can a Closed Carotid Artery Be Reopened?